$66.69
0.10.15%
At Close: -
$66.45
-0.24-0.36%
After Hours: 7:43 PM EDT
15 minutes delayed
Gilead Sciences (NASDAQ:GILD) 주식, 실적 예상치, EPS, 및 매출
Gilead Sciences은(는) 분기별로 실적을 보고합니다. 이 분기별 실적 보고서를 통해 투자자는 3개월 동안 회사의 재무 결과를 엿볼 수 있습니다. 실적 보고서에는 거의 항상 EPS 및 매출 결과가 포함됩니다..
실적 발표일
8월 1
EPS 추정치
$1.580
분기 매출 예상치
$6.7B
연간 매출
(기준 3월 31)
(기준 3월 31)
$27.4B
Gilead Sciences의 실적 이력을 고급 정렬 및 필터를 사용하여 분석하십시오.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | $1.34 | $1.58 | — | — | $6.60B | $6.69B | — | — | 08/01/2024 | Get Alert |
| GILD | Gilead Sciences | $1.37 | -$1.49 | -$1.32 | 11.41% | $6.35B | $6.34B | $6.69B | 5.46% | 04/25/2024 | Get Alert |
| GILD | Gilead Sciences | $1.67 | $1.78 | $1.72 | -3.37% | $7.39B | $7.09B | $7.12B | 0.35% | 02/06/2024 | Get Alert |
| GILD | Gilead Sciences | $1.90 | $1.92 | $2.29 | 19.27% | $7.04B | $6.80B | $7.05B | 3.69% | 11/07/2023 | Get Alert |
| GILD | Gilead Sciences | $1.58 | $1.61 | $1.34 | -16.77% | $6.26B | $6.43B | $6.60B | 2.63% | 08/03/2023 | Get Alert |
| GILD | Gilead Sciences | $2.12 | $1.54 | $1.37 | -11.04% | $6.59B | $6.33B | $6.35B | 0.35% | 04/27/2023 | Get Alert |
| GILD | Gilead Sciences | $0.69 | $1.49 | $1.67 | 12.08% | $7.24B | $6.64B | $7.39B | 11.28% | 02/02/2023 | Get Alert |
| GILD | Gilead Sciences | $2.65 | $1.48 | $1.90 | 28.38% | $7.42B | $6.12B | $7.04B | 15.07% | 10/27/2022 | Get Alert |
| GILD | Gilead Sciences | $1.87 | $1.53 | $1.58 | 3.27% | $6.22B | $5.86B | $6.26B | 6.83% | 08/02/2022 | Get Alert |
| GILD | Gilead Sciences | $2.08 | $1.80 | $2.12 | 17.78% | $6.42B | $6.28B | $6.59B | 4.94% | 04/28/2022 | Get Alert |
| GILD | Gilead Sciences | $2.19 | $1.58 | $0.69 | -56.33% | $7.42B | $6.64B | $7.24B | 9.10% | 02/01/2022 | Get Alert |
| GILD | Gilead Sciences | $2.11 | $1.74 | $2.65 | 52.30% | $6.58B | $6.25B | $7.42B | 18.74% | 10/28/2021 | Get Alert |
| GILD | Gilead Sciences | $1.11 | $1.73 | $1.87 | 8.09% | $5.14B | $6.07B | $6.22B | 2.42% | 07/29/2021 | Get Alert |
| GILD | Gilead Sciences | $1.68 | $2.09 | $2.08 | -0.48% | $5.55B | $6.74B | $6.42B | -4.70% | 04/29/2021 | Get Alert |
| GILD | Gilead Sciences | $1.30 | $2.15 | $2.19 | 1.86% | $5.88B | $7.33B | $7.42B | 1.24% | 02/04/2021 | Get Alert |
| GILD | Gilead Sciences | $1.75 | $1.95 | $2.11 | 8.21% | $5.60B | $6.39B | $6.58B | 2.93% | 10/28/2020 | Get Alert |
| GILD | Gilead Sciences | $1.82 | $1.45 | $1.11 | -23.45% | $5.68B | $5.31B | $5.14B | -3.15% | 07/30/2020 | Get Alert |
| GILD | Gilead Sciences | $1.76 | $1.57 | $1.68 | 7.01% | $5.28B | $5.45B | $5.55B | 1.80% | 04/30/2020 | Get Alert |
| GILD | Gilead Sciences | $1.44 | $1.67 | $1.30 | -22.16% | $5.79B | $5.71B | $5.88B | 2.96% | 02/04/2020 | Get Alert |
| GILD | Gilead Sciences | $1.84 | $1.74 | $1.75 | 0.57% | $5.60B | $5.61B | $5.60B | -0.11% | 10/24/2019 | Get Alert |
| GILD | Gilead Sciences | $1.91 | $1.72 | $1.82 | 5.81% | $5.65B | $5.51B | $5.68B | 3.18% | 07/30/2019 | Get Alert |
Gilead Sciences (GILD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-25 | $-1.32 | $-1.49 | 11.4 % |
| Dec 2023 | 2024-02-06 | $1.72 | $1.78 | -3.37 % |
| Sep 2023 | 2023-11-07 | $2.29 | $1.92 | 19.3 % |
| Jun 2023 | 2023-08-03 | $1.34 | $1.61 | -16.8 % |
Gilead Sciences (GILD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-25 | $6.69B | $6.34B | 5.46 % |
| Dec 2023 | 2024-02-06 | $7.12B | $7.09B | 0.35 % |
| Sep 2023 | 2023-11-07 | $7.05B | $6.80B | 3.69 % |
| Jun 2023 | 2023-08-03 | $6.60B | $6.43B | 2.63 % |
FAQ
Gilead Sciences (NASDAQ:GILD)의 실적 발표는 언제인가요?
Gilead Sciences (GILD)의 실적 발표가 8월 1, 2024에 예정되어 있습니다. 마지막으로 보고된 실적은 4월 25, 2024에 Q1에 대해 보고되었습니다.
Gilead Sciences (NASDAQ:GILD)의 최신 주당 순이익(EPS)은 얼마인가요?
실제 EPS는 $-1.32이며, 이는 $-1.49의 추정치를 뛰어넘다합니다.
Gilead Sciences (NASDAQ:GILD)의 매출은 얼마인가요?
실제 매출은 $6.7B이었으며, 이는 $6.3B의 추정치를 뛰어넘다합니다.
검색 실적 예상치, EPS, 및 매출 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved